These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8126264)

  • 1. Recurrent tumor vs radiation effects after gamma knife radiosurgery of intracerebral metastases: diagnosis with PET-FDG.
    Mogard J; Kihlström L; Ericson K; Karlsson B; Guo WY; Stone-Elander S
    J Comput Assist Tomogr; 1994; 18(2):177-81. PubMed ID: 8126264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
    Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography using 18F-fluorodeoxyglucose in patients with stereotactically irradiated brain metastases.
    Ericson K; Kihlström L; Mogard J; Karlsson B; Lindquist C; Widén L; Collins VP; Stone-Elander S
    Stereotact Funct Neurosurg; 1996; 66 Suppl 1():214-24. PubMed ID: 9032864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Although Non-diagnostic Between Necrosis and Recurrence, FDG PET/CT Assists Management of Brain Tumours After Radiosurgery.
    Torrens M; Malamitsi J; Karaiskos P; Valotassiou V; Laspas F; Andreou J; Stergiou C; Prassopoulos V
    In Vivo; 2016; 30(4):513-20. PubMed ID: 27381617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
    Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
    J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
    Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
    AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET/MRI Coregistration Helps Predict Response to Gamma Knife Radiosurgery in Patients With Brain Metastases.
    Leiva-Salinas C; Muttikkal TJE; Flors L; Puig J; Wintermark M; Patrie JT; Rehm PK; Sheehan JP; Schiff D
    AJR Am J Roentgenol; 2019 Feb; 212(2):425-430. PubMed ID: 30422717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography.
    Doyle WK; Budinger TF; Valk PE; Levin VA; Gutin PH
    J Comput Assist Tomogr; 1987; 11(4):563-70. PubMed ID: 3496366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
    Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K
    Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
    De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
    Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET-FDG of pleomorphic xanthoastrocytoma.
    Bicik I; Raman R; Knightly JJ; Di Chiro G; Fulham MJ
    J Nucl Med; 1995 Jan; 36(1):97-9. PubMed ID: 7799091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors.
    Janus TJ; Kim EE; Tilbury R; Bruner JM; Yung WK
    Ann Neurol; 1993 May; 33(5):540-8. PubMed ID: 8498831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma.
    Deshmukh A; Scott JA; Palmer EL; Hochberg FH; Gruber M; Fischman AJ
    Clin Nucl Med; 1996 Sep; 21(9):720-5. PubMed ID: 8879874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.
    Ceccon G; Lohmann P; Stoffels G; Judov N; Filss CP; Rapp M; Bauer E; Hamisch C; Ruge MI; Kocher M; Kuchelmeister K; Sellhaus B; Sabel M; Fink GR; Shah NJ; Langen KJ; Galldiks N
    Neuro Oncol; 2017 Feb; 19(2):281-288. PubMed ID: 27471107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose consumption in recurrent gliomas.
    Ishikawa M; Kikuchi H; Miyatake S; Oda Y; Yonekura Y; Nishizawa S
    Neurosurgery; 1993 Jul; 33(1):28-33. PubMed ID: 8355844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma.
    Fischman AJ; Thornton AF; Frosch MP; Swearinger B; Gonzalez RG; Alpert NM
    J Nucl Med; 1997 Jul; 38(7):1027-9. PubMed ID: 9225785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperacute changes in glucose metabolism of brain tumors after stereotactic radiosurgery: a PET study.
    Maruyama I; Sadato N; Waki A; Tsuchida T; Yoshida M; Fujibayashi Y; Ishii Y; Kubota T; Yonekura Y
    J Nucl Med; 1999 Jul; 40(7):1085-90. PubMed ID: 10405124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer.
    Greven KM; Williams DW; Keyes JW; McGuirt WF; Harkness BA; Watson NE; Raben M; Frazier LC; Geisinger KR; Cappellari JO
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):841-5. PubMed ID: 8040032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
    Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
    Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
    Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
    Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.